Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis : A Double Blinded Randomized Clinical Trial

NCT03679546 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT03679546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03679546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis : A Double Blinded Randomized Clinical Trial
Lead sponsor
Rennes University Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 4, 2019
Completion date
June 16, 2025
Enrollment
151 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis